Image

Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

Investigational Medication for Pancreaticobiliary Cancer

Recruiting
19 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates unresectable pancreaticobiliary cancer. It focuses on the effects of an investigational medication in patients receiving specific chemotherapy.

The study evaluates the medication's safety and effectiveness in reducing severe neutropenia.

  • Who can participate: Adults aged 19 years and older with unresectable pancreaticobiliary cancer who are scheduled for specific chemotherapy may join. Key exclusions include those who refuse consent or have had severe neutropenia during past chemotherapy.
  • Study details: Participants will receive an investigational medication alongside their chemotherapy. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
  • Study timelines: The study will last until June 30th, 2026.
Print
Study details
    Unresectable Pancreatic Cancer
    Unresectable Bile Duct Carcinoma
    Unresectable Biliary Tract Carcinoma

NCT06135896

National Cancer Center, Korea

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.